Russell T. Ray's Insider Trades & SAST Disclosures
Russell T. Ray's most recent trade in 180 Life Sciences Corp was a trade of 30,702 Common Stock done . Disclosure was reported to the exchange on Oct. 31, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Russell T. Ray.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 180 Life Sciences Corp | Russell T. Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 30,702 | 59,068 | - | 0 | Common Stock | |
| 180 Life Sciences Corp | Russell T. Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 13,068 | 28,366 | - | 0 | Common Stock | |
| 180 Life Sciences Corp | Russell T. Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 21,000 | 21,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| 180 Life Sciences Corp | Russell T. Ray | Director | Grant, award, or other acquisition of securities at price $ 1.36 per share. | 19 May 2022 | 10,570 | 15,298 | - | 1.4 | 14,375 | Common Stock |
| 180 Life Sciences Corp | Russell T. Ray | Director | Grant, award, or other acquisition of securities at price $ 3.04 per share. | 14 Jan 2022 | 4,728 | 4,728 | - | 3.0 | 14,373 | Common Stock |
| 180 Life Sciences Corp | Russell T. Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2021 | 79,000 | 79,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Merrimack Pharmaceuticals Inc | Russell T. Ray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2020 | 7,000 | 7,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges